April
Medicinal Chemistry
Strategy Meeting 2020
Accelerate Your Ability to Understand Methods For Data Mining Storing Integrating and Analysing Biological Data to Increase The Breadth of Drugs in R&D
ONLINE:
Medicinal Chemistry Strategy Meeting 2020
Following fantastic feedback we’re thrilled to announce we will be running another Online Medicinal Chemistry Strategy Meeting. This virtual conference format allows you to discuss key medicinal chemistry issues with your peers and forge new connections from the comfort of your own home.
Dates
10 Nov, 2020What makes our online strategy meeting unique?
No other event creates such a unique and personalised event experience. From the tailored agenda, to the senior delegation; our online strategy meetings provide the perfect learning and networking environment from the comfort of your own home or office.
Roundtable Discussions
Intimate discussions leads by a renowned expert. Have your voice heard alongside like-minded life science executives.
Intimate discussions leads by a renowned expert. Have your voice heard alongside like-minded life science executives.
Global Networking
With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.
With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Totally Online Format
It’s more important than ever to encourage collaboration while promoting safety and accessibility. And that’s exactly what you can expect from our online meeting format.
It’s more important than ever to encourage collaboration while promoting safety and accessibility. And that’s exactly what you can expect from our online meeting format.
Meet the Facilitators
Our panel of facilitators play a key role in shaping the agenda. See who will be bringing their expertise to the November Strategy Meeting:
Valery Polyakov
Director, Head of Computational Chemistry Sutro Biopharma
Peter Kotsonis
Executive Director, Office of Strategic Alliances, UCSF Innovation Ventures University of California
Govinda Bhisetti
Vice President and Head of Computational Chemistry CellarityGuy Lewy
CSO Sublime Therapeutics
Werngard Czechtizky
Executive Director, Head of Medicinal Chemistry, Respiratory and Immunology AstraZeneca
David Walker
Head of Chemistry, Director Sentinel Oncology
Syed Askari
Founder and CEO Maculus Therapeutix
Heinz Moser
Executive Director Novartis
Markus Haeberlein
Head of Research Alkermes
Guido Koch
Chief Executive Officer Amphilix AG
Bhushan Bonde
Head of IT-Early Solutions Innovation Development UCBReasons to Attend the Virtual Strategy Meeting
Fully Interactive Virtual Conference
We’re all bored of the same webinar format by now. Instead, join intimate groups of like-minded professionals and discuss the topics that really matter to you
Personalised and Easy to Join Agenda
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we will send you the direct links and calendar reminder to join
Senior Decision Makers
All our roundtable discussions are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard
Private and Intimate Discussions
Each sessions is read by an industry expert and the roundtables are limited to ensure you have fruitful and genuine conversations with your colleagues
Agenda
ARTIFICIAL INTELLIGENCE / MACHINE LEARNING – Since implemtation of AI in drug discovery, have we seen as big of an increase in preclinical success as we initially predicted or was it ‘overhyped’?
DESIGN & CUSTOM SYNTHESIS – Synthetic Route Selection – Getting it Right The First Time With ScaleUp in Mind
INTEGRATED DRUG DISCOVERY – TBC
HIT TO LEAD IDENTIFICATION – Don’t compromise on properties – successfully conducting multiparametric parallel optimization of hits
CHEMICAL BIOLOGY & CHEMINFORMATICS – Molecular adventures in 3D and 4D: What new ground is being opened up by cloud computing?
DISRUPTIVE TECHNOLOGIES – Speeding drug disocvery through effective collaborations
ARTIFICIAL INTELLIGENCE / MACHINE LEARNING – Tackling Noise and Uncertainty in Data-Driven Drug Discovery
DESIGN & CUSTOM SYNTHESIS – TBC
INTEGRATED DRUG DISCOVERY – TBC
HIT TO LEAD IDENTIFICATION – TBC
CHEMICAL BIOLOGY & CHEMINFORMATICS – Best tools to help retain the plethora of information extracted from 3D quantum mechanical modeling while converting to input for the machine learning model
DISRUPTIVE TECHNOLOGIES – How to improve current alliances and gain more effective collaborations
ARTIFICIAL INTELLIGENCE / MACHINE LEARNING – Will we ever actually move from an augmented drug design paradigm to an autonomous drug design paradigm?
DESIGN & CUSTOM SYNTHESIS – Utilising innovative chemical development approaches to reduce number synthesis steps
INTEGRATED DRUG DISCOVERY – What are the advantages and disadvantages of using an integrated drug discovery approach with one CRO?
HIT TO LEAD IDENTIFICATION – Developing cost-effective assays with sufficient throughput capacity
CHEMICAL BIOLOGY & CHEMINFORMATICS – Using cheminformatics to understand how drugs modify disease phenotypes to drive the shift from the single drug/single target paradigm
DISRUPTIVE TECHNOLOGIES – When? Where? How? – Best Outsourcing Practices and Strategies
See what’s next
Check out the full agenda from the 2020 Strategy Meeting, or find out more about upcoming events.
Thought Leader
Co-Hosts
Pro-partners
Payment Securely powered by stripe
